/Boston%20Scientific%20Corp_%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Valued at a market cap of $102.8 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties. The Marlborough, Massachusetts-based company focuses on addressing unmet clinical needs across a wide spectrum of complex conditions, including cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases. It is expected to announce its fiscal Q1 earnings for 2026 in the near future.
Before this event, analysts expect this healthcare company to report a profit of $0.80 per share, up 6.7% from $0.75 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $0.80 per share in the previous quarter exceeded the forecasted figure by 2.6%.
